Neuralink, Elon Musk's brain-chip startup, declared on Tuesday that the US Food and Drug Administration (FDA) had designated its experimental implant meant to restore eyesight as a "breakthrough device." This noteworthy accomplishment represents an important advancement in the creation of Neuralink's state-of-the-art medical technology, which is intended to cure serious medical diseases.
Neuralink, Elon Musk's brain-chip startup, declared on Tuesday that the US Food and Drug Administration (FDA) had designated its experimental implant meant to restore eyesight as a "breakthrough device." This noteworthy accomplishment represents an important advancement in the creation of Neuralink's state-of-the-art medical technology, which is intended to cure serious medical diseases.